241 related articles for article (PubMed ID: 28400392)
1. Identification of RUNX1 as a Mediator of Aberrant Retinal Angiogenesis.
Lam JD; Oh DJ; Wong LL; Amarnani D; Park-Windhol C; Sanchez AV; Cardona-Velez J; McGuone D; Stemmer-Rachamimov AO; Eliott D; Bielenberg DR; van Zyl T; Shen L; Gai X; D'Amore PA; Kim LA; Arboleda-Velasquez JF
Diabetes; 2017 Jul; 66(7):1950-1956. PubMed ID: 28400392
[TBL] [Abstract][Full Text] [Related]
2. TNF-α signaling regulates RUNX1 function in endothelial cells.
Whitmore HAB; Amarnani D; O'Hare M; Delgado-Tirado S; Gonzalez-Buendia L; An M; Pedron J; Bushweller JH; Arboleda-Velasquez JF; Kim LA
FASEB J; 2021 Feb; 35(2):e21155. PubMed ID: 33135824
[TBL] [Abstract][Full Text] [Related]
3. p38 promoted retinal micro-angiogenesis through up-regulated RUNX1 expression in diabetic retinopathy.
Zou W; Zhang Z; Luo S; Cheng L; Huang X; Ding N; Yu J; Pan Y; Wu Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32319515
[TBL] [Abstract][Full Text] [Related]
4. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
5. Cysteine-rich 61 (CYR61) is up-regulated in proliferative diabetic retinopathy.
Zhang X; Yu W; Dong F
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):661-8. PubMed ID: 22160564
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.
Kobayashi Y; Yoshida S; Zhou Y; Nakama T; Ishikawa K; Arima M; Nakao S; Sassa Y; Takeda A; Hisatomi T; Ikeda Y; Matsuda A; Sonoda KH; Ishibashi T
Mol Vis; 2016; 22():436-45. PubMed ID: 27186070
[TBL] [Abstract][Full Text] [Related]
7. TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy.
Yamaji Y; Yoshida S; Ishikawa K; Sengoku A; Sato K; Yoshida A; Kuwahara R; Ohuchida K; Oki E; Enaida H; Fujisawa K; Kono T; Ishibashi T
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3151-7. PubMed ID: 18316703
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of miR-200b/c by inhibiting vasohibin-2 in human retinal microvascular endothelial cells.
Ding Y; Hu Z; Luan J; Lv X; Yuan D; Xie P; Yuan S; Liu Q
Life Sci; 2017 Dec; 191():245-252. PubMed ID: 28882646
[TBL] [Abstract][Full Text] [Related]
9. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA.
Yan B; Yao J; Liu JY; Li XM; Wang XQ; Li YJ; Tao ZF; Song YC; Chen Q; Jiang Q
Circ Res; 2015 Mar; 116(7):1143-56. PubMed ID: 25587098
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
[TBL] [Abstract][Full Text] [Related]
11. Aberrant SUMO2/3 modification of RUNX1 upon SENP1 inhibition is linked to the development of diabetic retinopathy in mice.
Zhang W; Li F; Hou J; Cheng Y; Zhang W; Liang X; Wang J
Exp Eye Res; 2023 Dec; 237():109695. PubMed ID: 37890757
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Krüppel-Like Factor 9 Inhibits Aberrant Retinal Angiogenesis and Mitigates Proliferative Diabetic Retinopathy.
Han N; Zhang L; Guo M; Yu L
Mol Biotechnol; 2023 Apr; 65(4):612-623. PubMed ID: 36109428
[TBL] [Abstract][Full Text] [Related]
13. Runx1 regulates Tff1 expression to expedite viability of retinal microvascular endothelial cells in mice with diabetic retinopathy.
Zhang W; Zhang D; Cheng Y; Liang X; Wang J
Exp Eye Res; 2022 Apr; 217():108969. PubMed ID: 35114215
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
16. RUNX1 can mediate the glucose and O-GlcNAc-driven proliferation and migration of human retinal microvascular endothelial cells.
Xing X; Wang H; Niu T; Jiang Y; Shi X; Liu K
BMJ Open Diabetes Res Care; 2021 Aug; 9(1):. PubMed ID: 34348917
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
19. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
You JJ; Yang CH; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
[TBL] [Abstract][Full Text] [Related]
20. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
